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In 1983–87, we conducted a population-based case–control study of breast cancer in Asian women living in California and
Hawaii, in which migration history (a composite of the subject’s place of birth, usual residence in Asia (urban/rural), length of
time living in the West, and grandparents’ place of birth) was associated with a six-fold risk gradient that paralleled the
historical differences in incidence rates between the US and Asian countries. This provided the opportunity to determine
whether endogenous hormones vary with migration history in Asian-American women. Plasma obtained from 316
premenopausal and 177 naturally premenopausal study controls was measured for levels of estrone (E1), estradiol (E2),
estrone sulphate (E1S), androstenedione (A), testosterone (T), dehydroepiandrosterone (DHEA), dehydroepiandrosterone
sulphate (DHEAS), progesterone (PROG) and sex hormone-binding globulin (SHBG). Levels of the oestrogens and sex
hormone-binding globulin did not differ signiﬁcantly between Asian- and Western-born women, although among
premenopausal women, those least westernised had the lowest levels of E1, E2, and E1S. Androgen levels, particularly
DHEA, were lower in women born in the West. Among premenopausal women, age-adjusted geometric mean levels of
DHEA were 16.5 and 13.8 nmol l
71 in Asian- and Western-born women respectively; in postmenopausal women these
values were 11.8 and 9.2 nmol l
71,( P50.001) respectively. Among postmenopausal women, androgens tended to be highest
among the least westernised women and declined as the degree of westernisation increased. Our ﬁndings suggest that aspects
of hormone metabolism play a role in population differences in breast cancer incidence.
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Breast cancer incidence rates among US and Western European
women have been nearly six-fold higher than those in Asia. Since
the 1970’s studies of endogenous hormone levels in healthy Asian
and Caucasian women have produced varied results. Most
(MacMahon et al, 1974, 1980; Moore et al, 1983; Trichopoulos et
al, 1984; Goldin et al, 1986; Bernstein et al, 1990; Shimizu et al,
1990; Key et al, 1990), but not all (Bulbrook et al, 1976, Hayward
et al, 1978; Goodman et al, 1988; Porbst-Hensch, 2000) found
higher oestrogens in Caucasian women. In the few studies that
measured androgens (Bulbrook et al, 1967; Wang et al, 1976;
Hayward et al, 1978), levels were higher in Caucasian women.
The comparisons mainly concerned hormone levels in Asians living
in the East with those of Caucasian women in the West (see
Discussion) though a few studied Asian and Caucasian women
living in the same region in the West (Goldin et al, 1986; Good-
man et al, 1988; Probst-Hensch et al, 2000). In only two studies
were women selected as representative of a deﬁned population
(Bernstein et al, 1990; Probst-Hensch et al, 2000).
Different genetic susceptibilities alone are an unlikely explana-
tion for international differences in breast cancer incidence, since
rates among successive generations of Asian migrants to the West
approach those of Caucasians (Buell, 1973). More recently, the
magnitude of these differences has declined as a Western lifestyle
has spread in Asia (Coleman et al, 1993). In 1983–87, we
conducted a population-based case–control study of incident
breast cancer in Asian-American women in which women born
in the West had an approximate two-fold risk compared to those
who had migrated from Asia and a six-fold spread in risk when
additional aspects of migration history were considered (Ziegler
et al, 1993). This presented an opportunity to determine whether
endogenous hormones vary according to migration history among
women of Asian descent living in the US. To this end, we
measured the following steroid sex hormones and binding proteins
in the plasma of study controls: E1, E2, E1S, A, T, DHEA, DHEAS,
PROG, and SHBG.
MATERIALS AND METHODS
Study population
The design of this population-based study has been reported in
detail elsewhere (Ziegler et al, 1993). Brieﬂy, women of Chinese,
Japanese or Filipino descent, aged 20–55 years, and diagnosed with
E
p
i
d
e
m
i
o
l
o
g
y
Received 29 October 2001; revised 2 April 2002; accepted 3 April 2002
*Correspondence: RT Falk, Environmental Epidemiology Branch, National
Cancer Institute, 6120 Executive Boulevard MSC - 7234, Suite 7070,
Bethesda, Maryland, MD 20892, USA; E-mail: falkr@exchange.nih.gov.
British Journal of Cancer (2002) 87, 54–60
ã 2002 Cancer Research UK All rights reserved 0007–0920/02 $25.00
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and June 1987 in the San-Francisco–Oakland Metropolitan Statis-
tical Area (MSA), the Los Angeles MSA and Oahu, Hawaii were
identiﬁed. Population controls were frequency-matched to cases
in their region by ethnicity and year of birth, within 5 years.
Controls from San Francisco–Oakland and Los Angeles were
obtained by random-digit dialling; in Hawaii, controls were
obtained through the Health Surveillance Program which annually
samples 2% of households in the state. Where possible, a 2:1 ratio
of controls to cases was obtained. Participation rates among eligible
controls were as follows: Chinese 72%, Japanese 78%, and Filipino
73%.
Study methods
Participants were interviewed at home by trained interviewers in
the subject’s choice of language: Chinese, Japanese or English.
The questionnaire obtained information on the subject’s residential
history, place of birth of parents and grandparents, reproductive
and menstrual history, medical history and cancer in family
members, anthropometry and diet. Women were asked to identify
each country (and state, if in the US) in which they had lived for at
least 1 year, and for each, the length of time at that residence and
whether the community was urban (city or suburb) or rural (town,
village or rural area). Countries of birth considered part of the
‘East’ included: China, Taiwan, Hong Kong, Macao, Japan, the
Philippines, Southeast Asia, the Malaysian Peninsula, Singapore,
India and countries in the southwest Paciﬁc Ocean except Australia
and New Zealand. ‘West’ included countries in North America,
Western Europe, Central Europe, the former USSR, Australia and
New Zealand.
Among menstruating women, the blood draw was scheduled to
coincide with the mid-luteal phase, estimated to occur between
days 19 and 26 of the menstrual cycle. To facilitate this, women
were telephoned to determine the start date of their current
menstrual cycle and estimate the start of their next cycle. After
the blood draw, women were instructed to return a postcard indi-
cating the starting date of their next menses. Women were
considered postmenopausal if their last menses occurred more than
1 year prior to blood draw.
In the case-control study, a composite measure of several aspects
of migration history demonstrated a pattern of breast cancer risk
that paralleled the six-fold difference in incidence rates between
the US and Asian countries (Ziegler et al, 1993). Figure 1 shows
the ORs from the full case–control study according to this
measure with bars from left to right corresponding to the risks
for the least to the most westernised. All ORs were calculated in
relation to women born in the West whose grandparents were born
in the East. Thus, for example, the leftmost bar is the risk for those
born in the East in a rural environment and living in the US for
fewer than 8 years, while the rightmost bar is the risk for women
born in the West with three or more grandparents also born in the
West. For the subset of cases and controls participating in the
blood collection component, risks according to these categories
of migration history showed a similar pattern, with ORs increasing
from 0.4 to 1.2 (results not shown). In this study, westernisation
refers to this composite variable, with the exception being that
the two most westernised categories (born in the West with one
or two grandparents born in the West, and born in the West with
at least three grandparents born in the West; see legend to Figure
1) were combined because of the small number of women in each
category.
Laboratory methods
Fasting morning blood was drawn from participants into EDTA
tubes which were placed on ice and separated by centrifugation
within 3 h. Samples were then stored at 7708C until being sent
to a repository for long-term storage. Assays were conducted at
Quest Diagnostics, San Juan Capistrano, CA, USA, where E1,
E2, T, A, DHEA and PROG were measured by updated radioim-
munoassays (RIA) for the speciﬁc analyte after extraction from
plasma with ethyl acetate:hexane and puriﬁcation by celite chro-
matography (Quest Diagnostics Clinical Studies Center Reference
Manual, 1997; England et al, 1974; Judd et al, 1976; Abraham
et al, 1971, 1975, 1976; Gives, 1976; Korth-Schutz et al, 1978;
Kinouchi et al, 1973; Kirschner and Bardin, 1972; Rao and Moore,
1977; DePeretti and Forest, 1976). For E1S, unconjugated estrone
was extracted by ethyl acetate:hexane, hydrolyzed overnight with
the resultant E1 extracted and measured by RIA (Wright et al,
1978; Loriaux et al, 1971). DHEAS was measured directly by
RIA after dilution of plasma with assay buffer (DePeretti and
Forest, 1976; Buster and Abraham, 1972). SHBG was measured
by RIA (DSL, Webster, TX, USA). Per cent free E2 was calculated
by the method of So ¨dergard et al, 1982 and Vermeulen et al
(1999). Assay sensitivities were as follows: E2, 7.4 pmol l
71; E1,
36.7 pmol l
71; E1S, 142.7 pmol l
71; T, 0.07 nmol l
71;A ,
0.1 nmol l
71; DHEA, 4.6 nmol l
71; DHEAS, 0.14 mmol l
71;
SHBG 5.0 nmol l
71; PROG, 0.2 nmol l
71. Progesterone values
were obtained for the purpose of clarifying the time of menstrual
cycle and are not reported here.
The intra- and interassay CVs obtained from blinded quality
control samples added to our study batches were as follows: E2,
19% and 17%; E1, 4% and 9%; E1S, 8% and 10%; DHEA, 6%
and 3%; DHEAS, 5% and 8%; A, 8% and 7%; T, 6% and 6%;
SHBG, 4% and 4%; and PROG, 14% and 10%; respectively. The
relatively poor performance of the E2 assay was due to a quality
control pool with values near the assay limit of detection. Without
this specimen, the intra- and interassay CVs for E2 were 6 and 6%,
respectively.
Statistical methods
Hormone measurements were analysed on the natural logarithmic
scale to reduce the dependence of the variance on the mean
response. Assay results for premenopausal and postmenopausal
women were analysed separately. Geometric mean hormone levels
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Figure 1 Breast cancer odds ratios for Asian-American women accord-
ing to migration history. Migration categories are from left to right as fol-
lows: born in the East, rural in East, living in West 58 years; born in the
East, urban in East, living in West 58 years; born in the East, rural in East,
living in West 8+ years; born in the East, urban in East, living in West 8+
years; born in the West, all grandparents born in the East; born in the West,
one or two grandparents born West; born in the West, at least three
grandparents born in the West.
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adjusting for age at blood collection (continuous) and ethnicity.
Analyses of luteal phase bloods included additional adjustment
for the number of days between blood draw and subsequent
menses (continuous, modeled with linear and quadratic terms).
Differences in the distributions of menstrual, reproductive and
demographic characteristics according to place of birth were tested
using Chi-square statistics. Tests of trends in hormones across
levels of migration history were obtained by scoring the categories
and considering it a continuous variable in standard regression
models. Tests for hormone differences between speciﬁc levels of
the migration variable were obtained from appropriate contrasts.
Analyses were conducted using SYSTAT software (Wilkinson,
1986).
RESULTS
A total of 966 controls participated in the interview study. Of
these, fasting morning blood samples were obtained from 568
women, including 133 Chinese (46% participating), 276 Japanese
(70% participating) and 159 Filipino (56% participating) women.
Participation in the blood draw was higher among more wester-
nised women. Of those born in the East, 50% agreed to a blood
collection, whereas close to 70% of those born in the West agreed
to donate blood. This difference in blood collection participation
rate by place of birth was similar for the three ethnic groups.
Compared to women for whom we did not have a blood sample,
participants were slightly taller (P50.05), had a higher BMI
(P50.001), and were younger at menarche (P50.001), but were
similar with respect to age and other reproductive characteristics.
Of the 568 participating controls, bloods from 61 (11%) report-
ing exogenous hormone use were not assayed. Hormone
measurements were obtained for a total of 507 women, including:
317 premenopausal and 117 naturally postmenopausal women, 20
women with surgical removal of both ovaries, 11 women with
surgical removal of one ovary, 32 women with surgical removal
of the uterus only, eight with cessation of menses within 6–12
months of blood draw and two with unknown menopausal status.
For this study, we included only premenopausal or naturally post-
menopausal women not currently using exogenous hormones.
Excluding one premenopausal woman whose place of birth was
not known, this includes a total of 316 premenopausal and 117
naturally postmenopausal women.
Demographic and hormone-related factors
Selected demographic, anthropometric and reproduction-related
factors are shown in Table 1 according to place of birth. In both
pre- and postmenopausal women, the ethnic distribution differed
based on place of birth, with a majority of those born in the East
being Filipino, and most born in the West being of Japanese
descent. Neither the number of live births or age at ﬁrst birth
differed based on place of birth, but Western-born women were
signiﬁcantly younger at the start of menarche than Asian-born
participants. Women born in the West were slightly older at blood
draw, and among premenopausal women, those born in the West
weighed more than those born in the East.
Hormone levels
Premenopausal women Blood from only 202 of the 316
premenopausal women (64%) was considered as drawn in the
luteal phase, having been obtained between days 19–26 of the
menstrual cycle or having evidence of ovulation with progesterone
values above 9.54 nmol l
71. Analyses adjusted for age and ethni-
city were conducted with all premenopausal women, and
separately for the subset of luteal phase women with additional
adjustment for the number of days from blood draw to start of
menses (Table 2). Among the entire premenopausal group, no
signiﬁcant differences with regard to place of birth were observed
for the oestrogens, with levels of E1, E2, E1S and per cent free E2
each less than 5% lower in Western-born women. For the andro-
gens, differences in A and T were less than 5% and not
signiﬁcant, but DHEA and DHEAS were more than 10% lower
in Western-born women. For SHBG, the difference based on place
of birth was marginal, but values were signiﬁcantly lower in Fili-
pino women than in women of Chinese or Japanese descent.
Analyses restricted to luteal phase women showed similar patterns,
with marginal differences in the oestrogens based on place of
birth, and levels of DHEA and DHEAS more than 10% lower
in women born in the West. Adjusting for height, weight, BMI,
parity or ages at menarche and ﬁrst live birth did not alter the
pattern of these ﬁndings (results not shown).
Plots of mean hormone levels according to migration history are
shown for premenopausal women in Figure 2A (oestrogens and
SHBG) and Figure 3A (androgens). In interpreting these plots,
we note that few women were in the extreme categories of migra-
tion history (10 and 24 women in the least and most westernised
categories, respectively). No trends were observed in the oestrogens
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Table 1 Demographic, reproductive and anthropometric characteristics
of Asian-American women by place of birth and menopausal status
a
Premenopausal Postmenopausal
Birthplace Birthplace
East West East West
N (%) N (%) N (%) N (%)
Total 155 (100) 161 (100) 59 (100) 58 (100)
Ethnicity
Chinese 53 (34) 28 (17)
c 15 (25) 11 (19)
c
Japanese 33 (22) 123 (76) 12 (20) 40 (69)
Filipino 69 (44) 10 (6) 32 (54) 7 (12)
Number of live births
Never pregnant 29 (19) 17 (11) 6 (10) 5 (9)
No live births 2 (1) 2 (1) 2 (3) 0
1 23 (15) 31 (19) 8 (14) 6 (10)
2 53 (34) 64 (40) 13 (22) 16 (27)
3 31 (20) 27 (17) 11 (19) 12 (21)
4 7 (5) 14 (9) 6 (10) 9 (16)
5+ 10 (6) 6 (4) 13 (22) 10 (17)
Age at ﬁrst birth
Never pregnant 29 (19) 17 (11) 6 (10) 5 (9)
Number of live births 2 (1) 2 (1) 2 (3) 0
520 8 (5) 18 (11) 8 (14) 4 (7)
21–25 40 (26) 50 (31) 21 (35) 23 (39)
26–30 46 (30) 51 (32) 11 (19) 20 (34)
31–35 24 (19) 18 (11) 8 (14) 4 (7)
36+ 6 (1) 5 (3) 3 (5) 2 (3)
Age at menarche
512 19 (12) 51 (32)
b 1 (1) 12 (20)
b
12 34 (22) 56 (35) 9 (16) 16 (28)
13 38 (24) 29 (18) 16 (27) 16 (28)
14 27 (17) 16 (10) 8 (14) 8 (14)
15 23 (15) 5 (3) 5 (8) 2 (3)
16+ 14 (9) 4 (2) 20 (34) 4 (7)
Mean
(s.d.)
Mean (s.d.) Mean
(s.d.)
Mean (s.d.)
Age 42.1 (5.1) 43.9 (5.6)
b 54.5 (4.6) 55.9 (2.8)
b
Height (cm) 156.6 (5.0) 156.0 (12.3) 155.4 (5.6) 154.6 (4.8)
Weight (kg) 55.3 (8.3) 58.2 (12.3)
b 56.4 (8.5) 56.9 (9.1)
BMI (kg/m
2) 22.5 (3.0) 23.9 (4.9)
c 23.4 (3.5) 23.8 (4.1)
aExcludes one subject for whom place of birth was unknown;
bP50.05, difference
between women born in the East vs West;
cP50.001, difference between women
born in the East vs West.
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lowest among the least westernised women (the left most symbol
in Figure 2A). In particular, E2 values in these women were more
than 50% lower than values in the most westernised women
(P=0.11, difference in E2 between the extreme migration cate-
gories). Androgens did not trend with migration history (Figure
3A). Hormone patterns did not change with adjustment for weight,
height, BMI, parity or ages at menarche and ﬁrst birth (results not
shown).
Postmenopausal women After adjustment for age and ethnicity,
differences in the oestrogens based on place of birth were less than
5% and not signiﬁcant (Table 3). The androgens tended to be
lower in Western-born women, with differences of more than
10% observed for A and T. The difference in DHEA was signiﬁ-
cant, with levels more than 20% lower in Western-born women.
SHBG was higher in Western-born women, but this difference
was not signiﬁcant. As observed in premenopausal women, levels
of SHBG were signiﬁcantly lower in Filipino women compared
to women of Chinese or Japanese descent. Adjustment for weight,
height, BMI, parity, or ages at menarche and ﬁrst birth did not
change these ﬁndings (results not shown).
Plots of oestrogen and androgen levels according to migration
history are shown in Figures 2B and 3B, respectively, where the
number of postmenopausal women in the extreme categories was
very small (ﬁve and two, respectively in the least and most wester-
nized category). No trends according to migration history were
observed for the oestrogens in postmenopausal women. Androgen
levels tended to decline as the degree of westernisation increased
but only the trend for DHEA was suggestive (P, trend=0.06).
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Table 2 Geometric mean hormone levels among premenopausal
Asian-American women by place of birth
a
Birthplace
Per cent
East West difference
d
All premenopausal women
N 155 161
E1 (pmol l
71) 289.60 276.32 74.6
E2 (pmol l
71) 413.87 400.43 73.3
E1S (pmol l
71) 4548.27 4493.93 71.2
Free E2 (%) 2.65 2.73 3.0
A (nmol l
71) 3.83 3.66 74.5
T (nmol l
71) 0.88 0.85 73.3
DHEA (nmol l
71) 16.47 13.79 716.3
DHEAS (mmol l
71) 5.51 4.93 710.6
SHBG (nmol l
71) 36.71 35.85 71.2
Luteal phase women only
b
N 95 107
E1 (pmol l
71) 322.16 311.13 73.4
E2 (pmol l
71) 528.29 525.39 70.6
E1S (pmol l
71) 5241.72 5075.78 73.2
Free E2 (%) 2.56 2.66 3.9
A (nmol l
71) 3.95 3.99 1.0
T (nmol l
71) 0.88 0.89 0.9
DHEA (nmol l
71) 16.53 14.09 714.7
DHEAS (mmol l
71) 5.56 4.89 712.0
SHBG (nmol l
71) 42.38 39.90 75.9
aWomen currently on oral contraceptives excluded. Adjusted for age at blood draw
(continuous) and ethnicity;
bAdditional adjustment for number of days between
blood draw and subsequent menses (continuous);
cP50.05;
dPer cent difference
calculated relative to values among women born in the East.
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Figure 2 Oestrogen and SHBG levels in Asian-American women accord-
ing to migration history. (A) and (B) correspond to levels in pre- and post-
menopausal women respectively. Migration categories are from left to right
as follows (number of pre- and post-menopausal women in parentheses):
born in the East, rural in East, living in West 58 years (10, 5); born in the
East, urban in East, living in the West 58 years (37, 9); born in the East, rural
in East, living in West 8+ years (26, 11); born in the East, urban in East, living
in the West 8+ years (55, 22); born in the West, all grandparents born in the
East (137, 56); born in the West, at least one grandparent born in the West
(24,2). Excluded are 27 pre-, 12 postmenopausal women missing informa-
tion on type of residence in the East, number of years living in the West
or place of birth of grandparents. Plasma levels of E1, E2 E1S are in pmol
l
71; SHBG is in nmol l
71; free E2 is expressed as a per cent.
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Figure 3 Androgen levels in Asian-American women according to mi-
gration history. (A) and (B) correspond to levels in pre- and postmenopau-
sal women respectively. Migration categories are from left to right as
follows (number of pre- and post-menopausal women in paren.): born in
the East, rural in the East, living in the West 58 years (10, 5); born in
the East, urban in the East, living in the West 58 years (37, 9); born in
the East, rural in the East, living in the West 8+ years (26, 11); born in
the East, urban in the East, living in the West 8+ years (55, 22); born in
the West, all grandparents born in the East (137, 56); born in the West,
at least one grandparent born in the West (24,2). Excluded are 27 pre-,
12 postmenopausal women missing information on type of residence in
the East, number of years living in the West or place of birth of grandpar-
ents. Plasma levels of DHEA, A and T are in nmol l
71; for DHEAS, the level
is mmol l
71.
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In an effort to explain the international differences in breast cancer
incidence rates, a number of investigators have compared hormone
levels in healthy Asian and Caucasian women, with most focusing
on differences in oestrogen levels (MacMahon et al, 1974; Moore et
al, 1983; Trichopoulos et al, 1984; Goldin et al, 1986; Goodman et
al, 1988; Bernstein et al, 1990; Shimizu et al, 1990; Key et al, 1990;
Probst-Hensch et al, 2000) and a few examining androgens or
androgen precursors (Bulbrook et al, 1967; Wang et al, 1976;
Hayward et al, 1978). However, these studies could not distinguish
the role of genetic differences from the effects of an Asian lifestyle
on endogenous hormone levels. By limiting this study to women of
Asian descent in the US, we sought to isolate the inﬂuence of life-
style alone. Our main ﬁnding was that androgens, particularly
DHEA, were lower in Western-born Asian women; this was true
in both pre- and postmenopausal women. Moreover, in postmeno-
pausal women, the androgens tended to be highest among the least
westernised women and declined as the degree of westernisation
increased. For the oestrogens, levels between Asian- and Western-
born women were not signiﬁcantly different in pre- or postmeno-
pausal women, and no clear patterns according to degree of
westernisation were observed. In premenopausal women however,
oestrogens were lowest in the least westernised women. To the
extent that hormone levels among women in our extreme cate-
gories of westernisation reﬂect those of the Asian and Caucasian
women that have historically been studied, the small number –
15 and 26 women in the least and most westernised groups, respec-
tively – provided limited power to explore possible differences
between them.
The extensive literature on ethnic differences in endogenous
oestrogens is mixed. A number of factors may have contributed
to this inconsistency, the most important being the dramatic
improvement in assay methodology over the time these studies
were conducted. Before the 1990s, little attention had been paid
to the performance of steroid hormone assays within the normal
range, and problems with assay precision and accuracy could have
obscured small but consequential differences. Since then, a number
of studies have assessed laboratory assay reproducibility (Cauley et
al, 1991; Potischman et al, 1994; Hankinson et al, 1994; Toniolo et
al, 1994; Gail et al, 1996; Fears et al, 2000; Falk et al, 1999). Most
demonstrate that variability is not negligible from one batch to the
next even in the same laboratory, and rigorous quality control
efforts must be implemented to ensure the reliability of results.
Other reasons for inconsistencies across studies may relate to speci-
men collection, with samples ranging from a single urine or blood
draw to multiple collections over a 24 h period. Finally, compari-
sons across studies are complicated by study designs in which
women were not representative of the target populations (Bulbrook
et al, 1967, 1976; MacMahon et al, 1974, 1980; Wang et al, 1976;
Hayward et al, 1978; Moore et al, 1983; Trichopoulos et al, 1984;
Goldin et al, 1986; Goodman et al, 1988; Shimizu et al, 1990;
Key et al, 1990).
In light of these issues, we consider recent results from studies
conducted in deﬁned populations and using standardised assay
methods to be the most useful comparisons for our study. These
include ﬁndings from controls participating in a population-based
case-control study of breast cancer in the US and China (Bern-
stein et al, 1990), and hormone comparisons between Japanese-
Americans and US Caucasians participating in the Multiethnic
Cohort (Probst-Hensch et al, 2000). These studies showed oestro-
gens were higher in Caucasians than Asian women living in
China, but similar to, if not slightly lower than levels in Japa-
nese-Americans.
Concern that a single specimen may not correctly characterise
an individual’s hormone levels have long hampered efforts to
study endogenous hormones in premenopausal women. Indeed,
studies with blood collected between 1 and 3 years apart have
demonstrated that levels of androgens, but not oestrogens, tend
to be consistent from one year to the next (Muti et al, 1996;
Michaud et al, 1999; Hankinson et al, 1995). In particular, the
reproducibility of E2 was quite poor. By restricting analyses to
blood collected between 4–10 days prior to the next menses,
one study observed a dramatic improvement in the intraclass
correlation coefﬁcient (Michaud et al, 1999), suggesting that a
single, carefully scheduled blood collection may be sufﬁcient to
characterise luteal phase oestrogens. We found that compared to
the entire premenopausal group, estrogen levels in women known
to be in mid-luteal phase were higher overall, but differences
between those born in the East vs the West were similar in
magnitude and direction.
The ﬁnding of lower androgen levels in our Western-born
Asian women is provocative yet at variance with a few early
studies that found lower levels in Asian women compared to
Caucasians. As with the oestrogens, changes in androgen assays
limit our comparisons with these early investigations, and recent
studies of endogenous androgens are lacking. Since the patterns
of results for T, A, DHEA and DHEAS were very similar across
our indicator of westernisation, and the absolute levels of these
hormones were comparable to values reported in a recent study
using the same laboratory and assay procedures (Hankinson et
al, 1998), we are reasonably conﬁdent of the assay methods and
results. Nevertheless, interpretation of our ﬁndings is complicated
because participation in the blood collection component of the
study was inﬂuenced by a woman’s degree of westernisation.
Among Japanese and Chinese controls, those born in the West
were more likely to contribute blood than those born in the East
(for Japanese women, participation rates were 72 and 63% in
women born in the West vs the East; for Chinese, these ﬁgures
were 66 and 38%, respectively).
The study of migrant groups such as this one offers an oppor-
tunity to explore the role of hormonal factors that have ﬁgured
prominently in hypotheses attempting to explain large international
differences in breast cancer risk. Unfortunately, even though this is
the largest study of Asian women in the United States, the small
number of women in the most extreme categories of migration
history prevented us from clarifying much about changes in oestro-
gens with westernisation. The ﬁnding of a decline in androgens
with increasing westernisation is new, provocative, and consistent
with early experimental ﬁndings of antineoplastic effects of andro-
gens on oestrogen-induced carcinogenesis (Schwartz, 1979,
Schwartz and Tannen, 1981). By contrast, recent human studies
have suggested a hazardous role for androgens (Berrino et al,
1996; Dorgan et al, 1996, 1997; Zeleniuch-Jacquotte et al, 1997),
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Table 3 Geometric mean hormone level among postmenopausal
Asian-American women by place of birth
a
Birthplace
East West Per cent difference
59 58
E1 (pmol l
71) 90.80 86.47 74.8
E2 (pmol l
71) 29.85 31.17 4.4
E1S (pmol l
71) 843.98 826.92 72.0
Free E2 (%) 2.85 2.95 3.4
A (nmol l
71) 2.37 2.05 713.6
T (nmol l
71) 0.66 0.58 712.6
DHEA (nmol l
71) 11.80 9.18 722.2
b
DHEAS (mmol l
71) 3.50 3.46 71.2
SHBG (nmol l
71) 26.26 30.29 15.3
aWomen currently on hormone replacement therapy excluded. Values are adjusted
for age at blood draw (continuous) and ethnicity;
bP50.05;
cPer cent difference
calculated relative to values among women born in the East.
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Relatively little research has focused on a potential dual role of
androgens in breast neoplasia, although one study suggests that
DHEA may have differing effects depending on estradiol levels;
speciﬁcally, that DHEA stimulates cell growth in an estradiol-free
medium and inhibits growth in the presence of estradiol (Bocuzzi
et al, 1992). Future studies exploring the hormonal mechanisms
that may underlie breast cancer risk factors should focus their
efforts on a large spectrum of hormones including estrogens,
androgens and their metabolites.
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